"Every two minutes a woman in the United States is diagnosed with breast cancer," Maimah Karmo writes in an op-ed for the Washington Post.
"I thought I would become one of the thousands who would succumb to this relentless disease each year."
But 17 years after being diagnosed with triple negative breast cancer (TNBC), which is more aggressive and deadly among black women, Karmo, who is African American, writes that the fight against the disease "should be recognized and valued for how challenging and fragile" the process of bringing new treatments to patients is.
"Price controls would lead to less research and development (R&D) investment and fewer drug discoveries," she writes.
"The process of discovering and bringing a new drug to market involves substantial investments, time, and risks."
Karmo, who is also the founder of the Tigerlily Foundation, a national women's oncology and health foundation, writes that the Medicare Drug Price Negotiation Program (MDPNP) and similar drug price-setting policies " unintentionally threatens critical pathways for patients to access medicines that can help them survive complex diseases such as cancer" and could lead to 116 million life years lost over the next 20 years.
The MDPNP and similar policies "create additional barriers to treatment and care such
A customized collection of grant news from foundations and the federal government from around the Web.
Breathe Magic, an international program that incorporates specially adapted magic tricks and performance skills into therapy programs to improve physical and mental health outcomes for people of all ages, will be working or the benefit of children in Australia.